Diagnostik und Therapie der Akromegalie

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Der Internist

• Publication date

  2017-10-13

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s00108-017-0331-z
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurosurgical Treatment of Acromegaly.

  2016cited by this paper
• Current and Emerging Aspects of Diabetes Mellitus in Acromegaly.

  2016cited by this paper
• The role of colonoscopic screening in acromegaly revisited: review of current literature and practice guidelines

  2015influential reference
• Cardiovascular Disease and Sleep-Disordered Breathing in Acromegaly

  2015cited by this paper
• Assessment of the Presence of Carpal Tunnel Syndrome in Patients with Diabetes Mellitus, Hypothyroidism and Acromegaly.

  2015influential reference
• Thyroid autoimmune disorders in patients with acromegaly

  2015cited by this paper
• Surgery induced hypopituitarism in acromegalic patients: a systematic review and meta-analysis of the results

  2015cited by this paper
• Relationship between parenchymal involvement and obstructive sleep apnea in subjects with sarcoidosis

  2015cited by this paper
• Pituitary MRI characteristics in 297 acromegaly patients based on T2-weighted sequences.

  2015cited by this paper
• The Incidence of Cancer Among Acromegaly Patients: Results From the German Acromegaly Registry.

  2015influential reference
• Risk of Thyroid Nodular Disease and Thyroid Cancer in Patients with Acromegaly – Meta-Analysis and Systematic Review

  2014cited by this paper
• Acromegaly: an endocrine society clinical practice guideline.

  2014influential reference
• Acromegaly and bone disease

  2014cited by this paper
• Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial.

  2014cited by this paper
• Clinical characteristics of pain in patients with pituitary adenomas.

  2014cited by this paper
• FRAX score in acromegaly: does it tell the whole story?

  2014cited by this paper
• Vertebral fractures in patients with acromegaly: a 3-year prospective study.

  2013influential reference
• Effects of medical therapies for acromegaly on glucose metabolism.

  2013cited by this paper
• A consensus on the diagnosis and treatment of acromegaly complications

  2012cited by this paper
• Cognitive function in acromegaly: description and brain volumetric correlates

  2012cited by this paper
• The cardiovascular system in growth hormone excess and growth hormone deficiency

  2012influential reference
• Glucose homeostasis in patients with acromegaly treated with surgery or somatostatin analogues

  2011cited by this paper
• Goiter, cardiovascular and metabolic disorders in patients with acromegaly.

  2011cited by this paper
• American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly--2011 update.

  2011cited by this paper
• Thyroid cancer is the most common cancer associated with acromegaly

  2010cited by this paper
• Cardiovascular risk factors in patients with uncontrolled and long-term acromegaly: comparison with matched data from the general population and the effect of disease control.

  2010cited by this paper
• Modern imaging of pituitary adenomas.

  2010cited by this paper
• Guidelines for acromegaly management: an update.

  2009influential reference
• Prevalence of mental disorders in acromegaly: a cross‐sectional study in 81 acromegalic patients

  2009cited by this paper
• Age and sex as predictors of biochemical activity in acromegaly: analysis of 1485 patients from the German Acromegaly Register

  2009cited by this paper
• Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults

  2008cited by this paper
• Prevalence of sleep apnea and metabolic abnormalities in patients with acromegaly and analysis of cephalometric parameters by magnetic resonance imaging.

  2008cited by this paper
• The German Acromegaly Registry: description of the database and initial results.

  2006cited by this paper
• Systemic complications of acromegaly: epidemiology, pathogenesis, and management.

  2004cited by this paper
• Impact of disease activity on thyroid diseases in patients with acromegaly: basal evaluation and follow-up.

  2004cited by this paper
• Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess.

  2004cited by this paper
• Pegvisomant-induced serum insulin-like growth factor-I normalization in patients with acromegaly returns elevated markers of bone turnover to normal.

  2003cited by this paper
• Pituitary tumor registry: a novel clinical resource.

  2000cited by this paper
• Mortality and Cancer Incidence in Acromegaly: A Retrospective Cohort Study

  1998cited by this paper
• Determinants of clinical outcome and survival in acromegaly

  1994cited by this paper
• Modern imaging of the pituitary.

  1993influential reference
• Surgical management of acromegaly.

  1992cited by this paper
• Generalised peripheral nerve dysfunction in acromegaly: a study by conventional and novel neurophysiological techniques.

  1987cited by this paper
• Extrahypothalamic growth-hormone-releasing factor (GRF) secretion is a rare cause of acromegaly: plasma GRF levels in 177 acromegalic patients.

  1984influential reference

• Cardiovascular risk in patients with acromegaly vs. non-functioning pituitary adenoma following pituitary surgery: an active-comparator cohort study

  2024cites this paper
• Hypophysenadenome – nicht immer benigner Natur

  2018cites this paper